BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang K, Baldwin GS, Nikfarjam M, He H. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation. World J Gastroenterol 2018; 24(33): 3709-3723 [PMID: 30197477 DOI: 10.3748/wjg.v24.i33.3709]
URL: https://www.wjgnet.com/1007-9327/full/v24/i33/3709.htm
Number Citing Articles
1
Jian-Bo Shao, Xiang-Qian Luo, Li-Hua Mo, Gui Yang, Zhi-Qiang Liu, Jiang-Qi Liu, Zhi-Gang Liu, Da-Bo Liu, Ping-Chang Yang. Twist1 sustains the apoptosis resistance in eosinophils in nasal mucosa of allergic rhinitisArchives of Biochemistry and Biophysics 2021; 702: 108828 doi: 10.1016/j.abb.2021.108828
2
Nikolaos Symeonidis, Maria Lambropoulou, Efstathios Pavlidis, Constantinos Anagnostopoulos, Alexandra Tsaroucha, Athanasia Kotini, Christina Nikolaidou, Anastasia Kiziridou, Constantinos Simopoulos. PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic SignificanceClinical Medicine Insights: Oncology 2019; 13: 117955491983199 doi: 10.1177/1179554919831990
3
Keita Yamada, Kiyoshi Higashi, Hirohisa Nagahori, Koichi Saito. Circulating natural antibodies against 3’-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarcinomaCancer Biomarkers 2019; 27(1): 121 doi: 10.3233/CBM-190158
4
Ying Zhou, Jian Zhang, Jian Wang, Mao‐Sheng Cheng, Dong‐Mei Zhao, Feng Li. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1‐Related Signaling PathwaysThe Anatomical Record 2019; 302(9): 1571 doi: 10.1002/ar.24095
5
Baoyu Li, Bin Liu, Xianglian Zhang, Hui Liu, Lijie He. KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8Journal of Cellular Physiology 2020; 235(5): 4227 doi: 10.1002/jcp.29201
6
Kai Wang, Yifan Zhan, Nhi Huynh, Chelsea Dumesny, Xiao Wang, Khashayer Asadi, David Herrmann, Paul Timpson, Yang Yang, Katrina Walsh, Graham S. Baldwin, Mehrdad Nikfarjam, Hong He. Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1Cancer Letters 2020; 472: 8 doi: 10.1016/j.canlet.2019.12.020
7
Kai Wang, Hong He. Tumor Microenvironments in OrgansAdvances in Experimental Medicine and Biology 2020; 1296: 243 doi: 10.1007/978-3-030-59038-3_15
8
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer ProgressionFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
9
Chen Lu, Wei Jiang, Bingqing Hui, Dawei Rong, Kai Fu, Chaoxi Dong, Weiwei Tang, Hongyong Cao. The circ_0021977/miR‐10b‐5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancerJournal of Cellular Physiology 2020; 235(3): 2273 doi: 10.1002/jcp.29135
10
Lizhou Xu, Farid N. Faruqu, Yau M. Lim, Kee Y. Lim, Revadee Liam-Or, Adam A. Walters, Paul Lavender, David Fear, Claire M. Wells, Julie Tzu-Wen Wang, Khuloud T. Al-Jamal. Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatmentBiomaterials 2021; 264: 120369 doi: 10.1016/j.biomaterials.2020.120369
11
Wenting Wang, Zhijian Xu, Ning Wang, Ruyong Yao, Tao Qin, Hao Lin, Lu Yue. Prognostic value of eight immune gene signatures in pancreatic cancer patientsBMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-020-00868-w
12
Hsing-Yu Wu, Ming-Chen Yang, Li-Yun Ding, Ching S. Chen, Po-Chen Chu. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cellsCancer Letters 2019; 456: 13 doi: 10.1016/j.canlet.2019.04.026
13
Young-Lan Park, Sang-Yoon Ha, Sun-Young Park, Jung-Ho Choi, Min-Woo Jung, Dae-Seong Myung, Hyun-Soo Kim, Young-Eun Joo. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cellsInternational Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4746